These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16699319

  • 1. Use of chromogenic in situ hybridization to identify MYCN gene copy number in neuroblastoma using routine tissue sections.
    Thorner PS, Ho M, Chilton-MacNeill S, Zielenska M.
    Am J Surg Pathol; 2006 May; 30(5):635-42. PubMed ID: 16699319
    [Abstract] [Full Text] [Related]

  • 2. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
    Bhargava R, Oppenheimer O, Gerald W, Jhanwar SC, Chen B.
    Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689
    [Abstract] [Full Text] [Related]

  • 3. Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas.
    Korja M, Finne J, Salmi TT, Kalimo H, Karikoski R, Tanner M, Isola J, Haapasalo H.
    Mod Pathol; 2005 Dec; 18(12):1599-605. PubMed ID: 16258518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.
    Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, Suita S.
    J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373
    [Abstract] [Full Text] [Related]

  • 6. Concomitant DDX1 and MYCN gain in neuroblastoma.
    Defferrari R, Tonini GP, Conte M, Papio F, Sementa AR, Valent A, Schena F, Perri P, Mazzocco K.
    Cancer Lett; 2007 Oct 18; 256(1):56-63. PubMed ID: 17611020
    [Abstract] [Full Text] [Related]

  • 7. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction.
    Gotoh T, Hosoi H, Iehara T, Kuwahara Y, Osone S, Tsuchiya K, Ohira M, Nakagawara A, Kuroda H, Sugimoto T.
    J Clin Oncol; 2005 Aug 01; 23(22):5205-10. PubMed ID: 16051962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis.
    Marrano P, Irwin MS, Thorner PS.
    Genes Chromosomes Cancer; 2017 Jan 01; 56(1):28-41. PubMed ID: 27465929
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines.
    Kuzyk A, Booth S, Righolt C, Mathur S, Gartner J, Mai S.
    Genes Chromosomes Cancer; 2015 Oct 01; 54(10):616-28. PubMed ID: 26171843
    [Abstract] [Full Text] [Related]

  • 14. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues.
    Misra DN, Dickman PS, Yunis EJ.
    Diagn Mol Pathol; 1995 Jun 01; 4(2):128-35. PubMed ID: 7551293
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
    Hu HL, He LJ.
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug 01; 33(4):332-6. PubMed ID: 15363318
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A, Matsuoka K, Okita H, Iwafuchi H, Hori H, Kumagai M.
    Pediatr Dev Pathol; 2011 Aug 01; 14(2):87-92. PubMed ID: 21288077
    [Abstract] [Full Text] [Related]

  • 19. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
    Tajiri T, Tanaka S, Higashi M, Kinoshita Y, Takahashi Y, Tatsuta K, Suita S.
    J Pediatr Surg; 2006 Mar 01; 41(3):560-6. PubMed ID: 16516635
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.